Evidence map›Paper›PMID 15333691›Full record

ArticleNucleic acids research2004

Splicing affects presentation of RNA dimerization signals in HIV-2 in vitro.

Jean-Marc Lanchy, Quenna N Szafran, J Stephen Lodmell

Abstract readComparative Study
In one paragraph

Article in Nucleic acids research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jean-Marc LanchyDivision of Biological Sciences, The University of Montana, Missoula, MT 59812, USA.
Quenna N Szafran
J Stephen Lodmell

Funding

MT INBRE RESEARCH COREP20RR016455 · NCRR · MONTANA STATE UNIVERSITY - BOZEMAN · PI HARMSEN, ALLEN G · 2001 to 2011
$34.4M
HIV Genomic RNA StructureR01AI045388 · NIAID · UNIVERSITY OF MONTANA · PI LODMELL, J. STEPHEN · 2000 to 2008
$1.5M
HIV-2 Genomic RNA StructureR21AI045388 · NIAID · UNIVERSITY OF MONTANA · PI LODMELL, JOHN STEPHEN · 2004 to 2004
$240k
NCRR NIH HHS P20 RR016455NCRR NIH HHS P20RR-16455-03NIAID NIH HHS AI45388NIAID NIH HHS R01 AI045388NIAID NIH HHS R21 AI045388
6 · The paper itself

Abstract

During retroviral replication, full-length viral RNAs are encapsidated into new virus particles, while spliced RNAs are excluded. The Retroviridae are unique among viruses in that infectious viral particles contain a dimer of two identical genomic RNA strands. A variety of experimental data has suggested that dimerization and encapsidation of full-length viral RNAs are linked processes, although whether dimerization is a prerequisite for encapsidation, or conversely, dimerization follows encapsidation, has not been firmly established. If dimerization was the sole determinant for encapsidation, then spliced viral RNAs might be expected to display a reduced capacity for dimerization, resulting in their exclusion from the dimerization pool. Here, we studied the in vitro dimerization properties of unspliced and spliced HIV-2 RNA. We find that the rate and yield of dimerization of Nef, Rev and Tat spliced RNAs exceeded those of unspliced RNA. Although these data do not support a simple correlation between dimerization efficiency and the presence of introns, they establish that splicing affects the presentation of dimerization signal(s), which we corroborate with structure probing. This change in RNA conformation likely affects the RNA's suitability for packaging. Furthermore, the presence of upstream and downstream elements that affect the conformation of the packaging signal represents a potentially efficient viral strategy for correctly sorting spliced versus unspliced RNAs.

Indexed as

RNA SplicingBase SequenceDimerizationGene Products, nefGene Products, revGene Products, tatHIV-2HIV Long Terminal RepeatMolecular Sequence Datanef Gene Products, Human Immunodeficiency VirusNucleic Acid ConformationRegulatory Sequences, Ribonucleic Acidrev Gene Products, Human Immunodeficiency VirusRNA, MessengerRNA, ViralSignal TransductionGene Products, nefGene Products, revGene Products, tatnef Gene Products, Human Immunodeficiency VirusRegulatory Sequences, Ribonucleic Acidrev Gene Products, Human Immunodeficiency VirusRNA, MessengerRNA, Viraltat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID15333691
PMCPMC516069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.